![W.h. Ireland Group Plc](/common/images/company/L_WHI.png)
La société a généré un chiffre d'affaires record de 24,5 millions de dollars au cours de l'exercice 2024 et réalisé d'importantes avancées technologiques Augmente les capacités de laboratoire et...
Achieves Record $24.5 Million Revenue in FY 2024, Showcases Technological Advancements Expands Laboratory Capabilities and Launches Advanced AI Models, Aimed at Strengthening Market Position...
The Company to host an earnings conference call via webcast ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) today announces the rescheduling of its full year fiscal 2024...
ImmunoPrecise Antibodies Ltd. (la « société » ou « IPA ») (NASDAQ : IPA), une société de recherche et de technologie biothérapeutiques axée sur l’IA, annonce ce jour avoir conclu un contrat...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.25 | 3.4 | 3.2 | 999458 | 3.25842322 | DE |
4 | 0 | 0 | 3.25 | 3.4 | 2.5 | 1002207 | 3.25268232 | DE |
12 | -0.75 | -18.75 | 4 | 4 | 2.5 | 2710054 | 3.14263667 | DE |
26 | -1 | -23.5294117647 | 4.25 | 4.25 | 2.5 | 1577896 | 3.15219327 | DE |
52 | -3.75 | -53.5714285714 | 7 | 7 | 2.5 | 970566 | 3.92986212 | DE |
156 | -54.25 | -94.347826087 | 57.5 | 57.5 | 2.5 | 363873 | 10.42168311 | DE |
260 | -46.25 | -93.4343434343 | 49.5 | 58.5 | 2.5 | 232935 | 14.80961246 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.